Help stop hair thinning and regrow thicker, fuller hair.
1 in 4 women are affected by thinning hair.
The most common cause is hereditary hair loss (androgenetic alopecia) which causes 95% of women's hair loss.
Regaine for Women is specially formulated containing Minoxidil – the only clinically proven treatment applied direct to the scalp, to treat women’s thinning hair.
Always read the label and follow instructions for the best results. Apply a 1ml dose to the total affected area twice daily (with a 12 hour interval in between) using the appropriate applicator. Each applicator is designed to accurately release a 1ml dose when used as described in the Product information leaflet. (Do not exceed 2ml in a day and do not use more than twice a day)Exceeding the recommended dose will not re-grow your hair any more quickly and you may risk side effects.If you miss one or two applications, just carry on as normal as if you had not missed the dose – do not use twice as much or twice as often.Always wash your hands thoroughly after applying Regaine for Women Regular Strength and rinse other areas that have come into contact with Regaine for Women Regular Strength.
Always read the label.Do not exceed the stated dose. Regaine for Women Regular Strength should not be used in the following instances: If you suffer from a problem with blood pressure and/or receive treatment for it.If you have any condition that affects your scalp including sunburn and psoriasis.For sudden unexpected hair loss.For hair loss caused by drug treatment.If you are allergic to Minoxidil, ethanol or propylene glycol.If you are under 18 or over 65 years.If you are pregnant or breast feeding. Side-effects:Stop using regaine for Women Regular Strength if you get any of the following:blood pressure changesrapid heart beatnew or worsening pain in the chestdizziness, light-headedness, or faintingunexplained rapid weight gain of more than 2kg or 5lbswelling or puffiness of the hands or feetpersistent redness or irritation of the scalp Side-effects more commonly occur in women.